Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)

NCT ID: NCT01497756

Last Updated: 2020-02-26

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2011-08-31
• Study Completion Date: 2012-05-31

Brief Summary

A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.

Detailed Description

Providers will be surveyed twice at 4 and 8 months using open ended methods.

Conditions

Postpartum Hemorrhage

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

CAPP application

Patients in whom device is used

Group Type: EXPERIMENTAL

CAPP use

Intervention Type: DEVICE

Any abdominal pelvic pressure

Interventions

CAPP use

Any abdominal pelvic pressure

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Any patient receiving CAPP during study period.

Exclusion Criteria

• None (CAPP is only clinically indicated for obstetric hemorrhage post delivery.

• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

University of New Mexico

OTHER

Sponsor Role: lead

Responsible Party

Mark Hauswald

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Mark Hauswald, MD

Role: PRINCIPAL_INVESTIGATOR

University of New Mexico

Locations

University of New Mexico

Albuquerque, New Mexico, United States

Countries

United States

Other Identifiers

10-229

Identifier Type: -

Identifier Source: org_study_id